ContraFect Corp (CFRXQ)
0.015
0.00 (0.00%)
USD |
OTCM |
May 13, 11:53
ContraFect Cash from Investing (TTM): 12.80M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 12.80M |
June 30, 2023 | 17.57M |
March 31, 2023 | 30.08M |
December 31, 2022 | 32.08M |
September 30, 2022 | 29.01M |
June 30, 2022 | 34.12M |
March 31, 2022 | -11.78M |
December 31, 2021 | -11.61M |
September 30, 2021 | -11.76M |
June 30, 2021 | -26.35M |
March 31, 2021 | -16.49M |
December 31, 2020 | -27.40M |
September 30, 2020 | -32.25M |
June 30, 2020 | -20.73M |
March 31, 2020 | 10.14M |
December 31, 2019 | 21.97M |
September 30, 2019 | 26.39M |
June 30, 2019 | 21.55M |
March 31, 2019 | 19.70M |
December 31, 2018 | 17.15M |
Date | Value |
---|---|
September 30, 2018 | 20.79M |
June 30, 2018 | -12.83M |
March 31, 2018 | -13.17M |
December 31, 2017 | -9.360M |
September 30, 2017 | -16.29M |
June 30, 2017 | -8.806M |
March 31, 2017 | -6.061M |
December 31, 2016 | -8.969M |
September 30, 2016 | -24.56M |
June 30, 2016 | 2.545M |
March 31, 2016 | -8.541M |
December 31, 2015 | -21.60M |
September 30, 2015 | -8.768M |
June 30, 2015 | -11.68M |
March 31, 2015 | -10.48M |
December 31, 2014 | -1.610M |
September 30, 2014 | 0.645M |
June 30, 2014 | 1.448M |
March 31, 2014 | 1.863M |
December 31, 2013 | 1.589M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-32.25M
Minimum
Sep 2020
34.12M
Maximum
Jun 2022
4.296M
Average
11.47M
Median
Cash from Investing (TTM) Benchmarks
Athersys Inc | 1.968M |
Merck & Co Inc | -13.10B |
MEI Pharma Inc | 58.90M |
Bristol-Myers Squibb Co | -21.70B |
Predictive Technology Group Inc | -0.5082M |